Internal Medicine
Opinion: COVID-19 will continue but the end of the pandemic is near.
21 Jan, 2022 | 10:16h | UTCCOVID-19 will continue but the end of the pandemic is near – The Lancet
Commentary on Twitter
.@IHME_UW's Chris Murray predicting the end of the pandemic is nigh
"More than 50% of the world will have been infected with omicron …[by] the end of March, 2022"
"After the omicron wave, COVID-19 will return but the pandemic will not."https://t.co/9NSw8lZuUe @TheLancet— Eric Topol (@EricTopol) January 20, 2022
Europe considers new COVID-19 strategy: Accepting the virus.
21 Jan, 2022 | 10:13h | UTCEurope considers new COVID-19 strategy: Accepting the virus – Associated Press
Perspective: Nervous system consequences of COVID-19.
21 Jan, 2022 | 10:10h | UTCNervous system consequences of COVID-19 – Science
Related:
Review: Counting the neurological cost of COVID-19.
Neurological Effects of COVID-19 in Children.
International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.
Short review: Neurological complications of COVID-19.
2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.
M-A: Encephalitis as Neurological Complication of COVID‐19.
Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditionsEight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).
Commentary on Twitter
A new #SciencePerspective discusses the neurological symptoms that accompany #COVID19 and the possible mechanisms that cause them. Read more: https://t.co/WKZpnWlbNc pic.twitter.com/U4ohecaVQd
— Science Magazine (@ScienceMagazine) January 20, 2022
Review: Postdischarge Evaluation for Individuals Hospitalized with COVID-19.
21 Jan, 2022 | 10:08h | UTCPostdischarge Evaluation for Individuals Hospitalized with COVID-19 – Southern Medical Journal
Perioperative guidelines on antiplatelet and anticoagulant agents: 2022 Update.
21 Jan, 2022 | 09:53h | UTC
Systematic Review: In people with Alzheimer’s disease and vascular dementia with agitation and psychosis, atypical antipsychotics probably reduce agitation slightly (moderate‐certainty evidence) but probably have a negligible effect on psychosis or risk of any adverse event.
21 Jan, 2022 | 09:50h | UTC
Sleeping on the LEFT side seems to be associated with reduced nocturnal acid exposure compared with supine and right lateral decubitus positions.
21 Jan, 2022 | 09:45h | UTCAssociations Between Sleep Position and Nocturnal Gastroesophageal Reflux: A Study Using Concurrent Monitoring of Sleep Position and Esophageal pH and Impedance – American Journal of Gastroenterology (link to abstract – $ for full-text)
Review: Diagnostic evaluation of gastric motor and sensory disorders.
21 Jan, 2022 | 09:42h | UTCDiagnostic Evaluation of Gastric Motor and Sensory Disorders – American Journal of Gastroenterology
M-A: No difference in outcomes with Beta-lactam monotherapy vs. combination therapy for bloodstream infections or pneumonia due to P. aeruginosa.
21 Jan, 2022 | 09:37h | UTCBeta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis – International Journal of Antimicrobial Agents (link to abstract – $ for full-text)
Cluster Randomized Trial: A multifactorial falls prevention program in UK care homes reduced fall rates among older people and was cost effective.
21 Jan, 2022 | 09:21h | UTCNews Release: Falls in care homes can be significantly reduced with intervention, says new study – University of Nottingham
Commentary on Twitter
NEW RESEARCH: A falls prevention programme for older people in care homes, co-designed with care home staff & residents, that involved awareness raising, education, screening, decision & implementation support was associated with a reduction in falls rate https://t.co/wupI0LeAxj
— The BMJ (@bmj_latest) December 11, 2021
Booster longevity: Data reveals how long a third shot protects.
20 Jan, 2022 | 09:33h | UTCBooster longevity: Data reveals how long a third shot protects – NPR
Original Report: SARS-CoV-2 variants of concern and variants under investigation in England – U.K. Health Security Agency
A populational-based retrospective cohort study in Qatar showed a reduced risk of Covid-19 breakthrough infections with the Moderna vs. the Pfizer–BioNTech vaccine.
20 Jan, 2022 | 09:30h | UTCEffectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar – New England Journal of Medicine
Commentary on Twitter
In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273, both were highly effective at preventing hospitalization & death. Breakthrough infections were lower among those who received mRNA-1273 than those who received BNT162b2. https://t.co/wgkrzfLNHz pic.twitter.com/E8hXIDFqWW
— NEJM (@NEJM) January 19, 2022
Milder disease with Omicron: is it the virus or the pre-existing immunity?
20 Jan, 2022 | 09:28h | UTC
Short Review: Fluvoxamine for symptomatic outpatients with COVID-19.
20 Jan, 2022 | 09:25h | UTCFluvoxamine for symptomatic outpatients with COVID-19 – Canadian Medical Association Journal
Related:
Fluvoxamine for Covid-19: What Prescribers and Pharmacists Need to Know.
Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
20 Jan, 2022 | 09:17h | UTCGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Commentary: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Commentary on Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
RCT: Among patients with recurrent Clostridioides difficile infection, the use of SER-109, an oral microbiome therapy, reduced recurrence rate compared to placebo (12% vs. 40%).
20 Jan, 2022 | 09:11h | UTCSER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection – New England Journal of Medicine (link to abstract – $ for full-text)
Meta-analysis of randomized controlled trials: Drug treatment for panic disorder with or without agoraphobia.
20 Jan, 2022 | 09:06h | UTC
Study shows that the retinal age gap might be a potential biomarker of aging linked to increased mortality risk.
20 Jan, 2022 | 09:04h | UTCRetinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
News Release: Difference between retina’s biological age and person’s real age linked to heightened death risk – BMJ
Commentary on Twitter
Difference between retina’s biological age and person’s real age linked to heightened death risk finds @BMJ_Ophth study https://t.co/TNveo5E77D
— BMJ (@bmj_company) January 19, 2022
M-A: the accuracy of serological tests to support the diagnosis of celiac disease.
20 Jan, 2022 | 09:02h | UTC
Systematic Review: Prevalence, incidence and survival of heart failure.
20 Jan, 2022 | 09:00h | UTCPrevalence, incidence and survival of heart failure: a systematic review – Heart
Review: Evaluating the patient with a pulmonary nodule.
20 Jan, 2022 | 08:56h | UTCEvaluating the Patient With a Pulmonary Nodule: A Review – JAMA (free for a limited period)
Author Interview: Evaluation and Management of Patients With Pulmonary Nodules
Review: Diagnosis and treatment of polycystic ovary syndrome.
20 Jan, 2022 | 08:54h | UTCDiagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
20 Jan, 2022 | 08:52h | UTC
Consensus Statement: Exercise/physical activity in individuals with Type 2 Diabetes.
20 Jan, 2022 | 08:51h | UTC
Commentary from the author on Twitter
Exercise/Physical Activity in Individuals with
Type 2 Diabetes: A Consensus Statement from
the American College of Sports Medicine
Honored to contribute w/several esteemed colleagues to this report now out on #exercise & #diabetes @MSSEonline @ACSMNews https://t.co/UNmoU2BgLR— Juleen R. Zierath (@JuleenRZierath) January 14, 2022
M-A: Association of Sodium-Glucose Cotransporter 2 Inhibitors with cardiovascular outcomes in patients with Type 2 Diabetes and other risk factors for cardiovascular disease.
20 Jan, 2022 | 08:42h | UTC
Commentary on Twitter
This meta-analysis found that use of SGLT2-Is was associated with lower occurrence of cardiovascular death or hospitalization for heart failure by 33% in high-risk patients. @mukul_bhattarai @AkcharAl @AbhiKulk82 @mominsiddique01 @Mohsin_Salih19 https://t.co/omPP6Qwofg
— JAMA Network Open (@JAMANetworkOpen) January 5, 2022